Managed by Global Brain, the new fund will mainly seek overseas startups focused on frontier biotech.
Japanese pharmaceutical sales and logistics company Toho Holdings is setting up a new ventures fund with VC firm Global Brain to invest in early-stage startups.
The Toho-GB Global Life Science Fund will target companies working in what it describes as cutting-edge drug discovery and biotechnology involving AI, data science and genetic engineering. The fund is focused on overseas markets.
Global Brain will manage the fund and will partner with Toho to help commercialise the portfolio companies’ technologies.
For Global Brain, this is the third large fund announcement it has made in the past two months, following the October launch of two funds it will manage for real estate development company Mitsui Fudosan, as well as a joint venture with Sony Financial Group to manage new VC funds.
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
